MAPT and neurodegenerative disease: Recent studies have suggested that the molecular level of autophagic maintenance might be a suitable way to treat AD as well as some other neurodegenerative diseases, since it could not only prevent cell death but also effectively degrade pathological proteins, such as Aβ, p-Tau, α-synuclein, and glutamine repeats (Ghavami et al., 2014).